4//SEC Filing
Zaderej Karen L. 4
Accession 0001562180-25-003873
CIK 0001314102other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:06 PM ET
Size
7.5 KB
Accession
0001562180-25-003873
Insider Transaction Report
Form 4
Zaderej Karen L.
Director
Transactions
- Purchase
Common Stock
2025-05-14$5.42/sh+5,000$27,100→ 21,500 total - Purchase
Common Stock
2025-05-15$5.47/sh+5,000$27,350→ 26,500 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.41 to $5.42. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.45 to $5.48. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001530968
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:06 PM ET
- Size
- 7.5 KB